148 related articles for article (PubMed ID: 8653319)
1. Urinary concentration of human chorionic gonadotrophin and its fragments as a prognostic marker in bladder cancer.
Iles RK; Persad R; Trivedi M; Sharma KB; Dickinson A; Smith P; Chard T
Br J Urol; 1996 Jan; 77(1):61-9. PubMed ID: 8653319
[TBL] [Abstract][Full Text] [Related]
2. Beta human chorionic gonadotrophin in serum and urine. A marker for metastatic urothelial cancer.
Iles RK; Jenkins BJ; Oliver RT; Blandy JP; Chard T
Br J Urol; 1989 Sep; 64(3):241-4. PubMed ID: 2478247
[TBL] [Abstract][Full Text] [Related]
3. Is beta-human chorionic gonadotrophin production by transitional cell carcinoma of the bladder a marker of aggressive disease and resistance to radiotherapy?
Moutzouris G; Yannopoulos D; Barbatis C; Zaharof A; Theodorou C
Br J Urol; 1993 Dec; 72(6):907-9. PubMed ID: 7508330
[TBL] [Abstract][Full Text] [Related]
4. [Urinary hCG beta-core fragment as a tumor marker for bladder cancer].
Yamanaka N; Kawabata G; Morisue K; Hazama M; Nishimura R
Nihon Hinyokika Gakkai Zasshi; 1993 Apr; 84(4):700-6. PubMed ID: 8492514
[TBL] [Abstract][Full Text] [Related]
5. Measurement of urinary beta core fragment of human chorionic gonadotrophin in women with vulvovaginal malignancy and its prognostic significance.
Carter PG; Iles RK; Neven P; Ind TE; Shepherd JH; Chard T
Br J Cancer; 1995 Feb; 71(2):350-3. PubMed ID: 7530986
[TBL] [Abstract][Full Text] [Related]
6. Assessment of urinary beta-core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer.
Yoshimura M; Nishimura R; Murotani A; Miyamoto Y; Nakagawa T; Hasegawa K; Koizumi T; Shii K; Baba S; Tsubota N
Cancer; 1994 Jun; 73(11):2745-52. PubMed ID: 7514953
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of beta human chorionic gonadotrophin in blood serum of patients with urinary bladder tumours.
Dobrowolski ZF; Byrska B; Dolezal M
Int Urol Nephrol; 1994; 26(3):301-6. PubMed ID: 7525501
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.
Durkan GC; Nutt JE; Rajjayabun PH; Neal DE; Lunec J; Mellon JK
Clin Cancer Res; 2001 Nov; 7(11):3450-6. PubMed ID: 11705862
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of urinary beta core fragment in premenopausal women with carcinoma of the cervix.
Carter PG; Iles RK; Neven P; Ind TE; Shepherd JH; Chard T
Gynecol Oncol; 1994 Nov; 55(2):271-6. PubMed ID: 7525427
[TBL] [Abstract][Full Text] [Related]
10. Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma.
Gerhards S; Jung K; Koenig F; Daniltchenko D; Hauptmann S; Schnorr D; Loening SA
Urology; 2001 Apr; 57(4):675-9. PubMed ID: 11306379
[TBL] [Abstract][Full Text] [Related]
11. CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients.
Zhu X; Qiao Y; Liu W; Wang W; Shen H; Lu Y; Hao G; Zheng J; Tian Y
Tumour Biol; 2016 Apr; 37(4):4569-77. PubMed ID: 26503215
[TBL] [Abstract][Full Text] [Related]
12. Chorionic gonadotropin beta-subunit and core fragment in bladder cancer: mRNA and protein expression in urine, serum and tissue.
Hotakainen K; Haglund C; Paju A; Nordling S; Alfthan H; Rintala E; Stenman UH
Eur Urol; 2002 Jun; 41(6):677-85. PubMed ID: 12074787
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of the tissue expression of human chorionic gonadotropin (beta-HCG) in infiltrating transitional carcinoma of the bladder].
De Castro F; Robledo C; Agüera L; Rosell D; Robles JE; Zudaire JJ; Berián JM
Actas Urol Esp; 1993 Apr; 17(4):259-63. PubMed ID: 8342417
[TBL] [Abstract][Full Text] [Related]
14. Urinary bladder cancer test: a new urinary tumor marker in the follow-up of superficial bladder cancer.
Mungan NA; Vriesema JL; Thomas CM; Kiemeney LA; Witjes JA
Urology; 2000 Nov; 56(5):787-92. PubMed ID: 11068302
[TBL] [Abstract][Full Text] [Related]
15. Ectopic human chorionic gonadotrophin (HCG) production: is the detection by serum analysis of HCG of clinical relevance in transitional cell carcinoma of the bladder?
Smith DJ; Evans HJ; Newman J; Chapple CR
Br J Urol; 1994 Apr; 73(4):409-12. PubMed ID: 8199829
[TBL] [Abstract][Full Text] [Related]
16. Composition of intact hormone and free subunits in the human chorionic gonadotrophin-like material found in serum and urine of patients with carcinoma of the bladder.
Iles RK; Lee CL; Oliver RT; Chard T
Clin Endocrinol (Oxf); 1990 Sep; 33(3):355-64. PubMed ID: 1701369
[TBL] [Abstract][Full Text] [Related]
17. Urinary chorionic gonadotropin subunits and beta-core in nonpregnant women. A study of benign and malignant gynecologic disorders.
Neven P; Iles RK; Lee CL; Hudson CN; Shepherd JH; Chard T
Cancer; 1993 Jun; 71(12):4124-30. PubMed ID: 7685240
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of beta human chorionic gonadotrophin and its metabolites in women with cervical carcinoma.
Crawford RA; Iles RK; Carter PG; Caldwell CJ; Shepherd JH; Chard T
J Clin Pathol; 1998 Sep; 51(9):685-8. PubMed ID: 9930074
[TBL] [Abstract][Full Text] [Related]
19. Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.
Badgwell D; Lu Z; Cole L; Fritsche H; Atkinson EN; Somers E; Allard J; Moore RG; Lu KH; Bast RC
Gynecol Oncol; 2007 Sep; 106(3):490-7. PubMed ID: 17532030
[TBL] [Abstract][Full Text] [Related]
20. Human chorionic gonadotropin measurements in parathyroid carcinoma.
Rubin MR; Bilezikian JP; Birken S; Silverberg SJ
Eur J Endocrinol; 2008 Oct; 159(4):469-74. PubMed ID: 18625691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
